Two Sigma Securities’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Two Sigma Securities’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,008	Closed	-$8K	–	2547
2019 Q1	$8K	Sell	1,008 -769	-43%	-$7.94K	﹤0.01%	1739
2018 Q4	$28K	Buy	+1,777	New	+$39.1K	﹤0.01%	1965
2017 Q3	–	Sell	-1,316	Closed	-$29K	–	1327
2017 Q2	$29K	Buy	+1,316	New	+$10.4K	0.01%	761
2017 Q1	–	Sell	-1,474	Closed	-$8K	–	1195
2016 Q4	$8K	Buy	+1,474	New	+$9.83K	﹤0.01%	681

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Two Sigma Securities's AVEO Position: Q2 2019 in Review

Two Sigma Securities sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2019, closing a stake of 1,008 shares — an estimated $8K sold.

Two Sigma Securities first reported a position in AVEO in Q4 2016 and held it in 4 quarters. The position peaked at $29K in Q2 2017. 73 funds tracked by Wall St. Rank hold AVEO as of Q2 2019.

Two Sigma Securities reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Two Sigma Securities sold 1,008 AVEO Pharmaceuticals, Inc. shares in Q2 2019, an estimated $8K.
Two Sigma Securities first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2016 and held it in 4 quarters.
Two Sigma Securities's AVEO Pharmaceuticals, Inc. position peaked at $29K in Q2 2017.
73 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2019.

Based on Two Sigma Securities's 13F filing for Q2 2019, filed 14 Aug 2019.